{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:07Z","timestamp":1790651947653,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971301"],"award-info":[{"award-number":["31971301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171324"],"award-info":[{"award-number":["32171324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2020CDJQY-A061"],"award-info":[{"award-number":["2020CDJQY-A061"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2018CDHB1B08"],"award-info":[{"award-number":["2018CDHB1B08"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0149"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0149"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some challenges such as high clearance rate and insufficient targeting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we report a biomimetic ROS-responsive MM@PCM\/RAP nanoparticle coated with macrophage membrane. The macrophage membrane with the innate \u201choming\u201d capacity can superiorly regulate the recruitment of MM@PCM\/RAP to inflammatory lesion to enhance target efficacy, and can also disguise MM@PCM\/RAP nanoparticle as the autologous cell to avoid clearance by the immune system. In addition, MM@PCM\/RAP can effectively improve the solubility of rapamycin and respond to the high concentration level of ROS accumulated in pathological lesion for controlling local cargo release, thereby increasing drug availability and reducing toxic side effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings validate that the rational design, biomimetic nanoparticles MM@PCM\/RAP, can effectively inhibit the pathological process of intimal injury with excellent biocompatibility.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-021-01119-5","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:21:43Z","timestamp":1637320903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia"],"prefix":"10.1186","volume":"19","author":[{"given":"Boyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Maruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-5135","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"1119_CR1","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1038\/s41467-019-10784-y","volume":"10","author":"P Luan","year":"2019","unstructured":"Luan P, Jian W, Xu X, Kou W, Yu Q, Hu H, et al. NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPAR\u03b3. Nat Commun. 2019;10:2882.","journal-title":"Nat Commun"},{"key":"1119_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118:692\u2013702.","journal-title":"Circ Res"},{"key":"1119_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/acscentsci.8b00050","volume":"4","author":"H Wang","year":"2018","unstructured":"Wang H, Agarwal P, Zhao G, Ji G, Jewell CM, Fisher JP, et al. Overcoming ovarian cancer drug resistance with a cold responsive nanomaterial. ACS Cent Sci. 2018;4:567\u201381.","journal-title":"ACS Cent Sci"},{"key":"1119_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12951-021-00867-8","volume":"19","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu P, Song Y, Li S, Shi Y, Quan K, et al. A heparin\u2013rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis. J Nanobiotechnol. 2021;19:123.","journal-title":"J Nanobiotechnol"},{"key":"1119_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.addr.2006.01.015","volume":"58","author":"NA Scott","year":"2006","unstructured":"Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev. 2006;58:358\u201376.","journal-title":"Adv Drug Deliv Rev"},{"key":"1119_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14779072.2021.1856657","volume":"19","author":"A Sakamoto","year":"2021","unstructured":"Sakamoto A, Sato Y, Kawakami R, Cornelissen A, Mori M, Kawai K, et al. Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges. Expert Rev Cardiovasc Ther. 2021;19:1\u201316.","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"1119_CR7","doi-asserted-by":"publisher","first-page":"1903204","DOI":"10.1002\/advs.201903204","volume":"7","author":"S Maslanka Figueroa","year":"2020","unstructured":"Maslanka Figueroa S, Fleischmann D, Beck S, Tauber P, Witzgall R, Schweda F, et al. Nanoparticles mimicking viral cell recognition strategies are superior transporters into mesangial cells. Adv Sci. 2020;7:1903204.","journal-title":"Adv Sci"},{"key":"1119_CR8","doi-asserted-by":"publisher","first-page":"eabd7563","DOI":"10.1126\/sciadv.abd7563","volume":"6","author":"CM Hamadani","year":"2020","unstructured":"Hamadani CM, Goetz MJ, Mitragotri S, Tanner EEL. Protein-avoidant ionic liquid (PAIL)\u2013coated nanoparticles to increase bloodstream circulation and drive biodistribution. Sci Adv. 2020;6:eabd7563.","journal-title":"Sci Adv."},{"key":"1119_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/0885328217712110","volume":"32","author":"Y Guo","year":"2017","unstructured":"Guo Y, Xu H, Li Y, Wu F, Li Y, Bao Y, et al. Hyaluronic acid and Arg-Gly-Asp peptide modified graphene oxide with dual receptor-targeting function for cancer therapy. J Biomater Appl. 2017;32:54\u201365.","journal-title":"J Biomater Appl"},{"key":"1119_CR10","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1002\/smll.201203106","volume":"9","author":"O Akhavan","year":"2013","unstructured":"Akhavan O, Ghaderi E. Graphene nanomesh promises extremely efficient in vivo photothermal therapy. Small. 2013;9:3593\u2013601.","journal-title":"Small"},{"key":"1119_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tips.2020.11.008","volume":"42","author":"LM Bush","year":"2021","unstructured":"Bush LM, Healy CP, Javdan SB, Emmons JC, Deans TL. Biological cells as therapeutic delivery vehicles. Trends Pharmacol Sci. 2021;42:106\u201318.","journal-title":"Trends Pharmacol Sci"},{"key":"1119_CR12","doi-asserted-by":"publisher","first-page":"1706759","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30:1706759.","journal-title":"Adv Mater"},{"key":"1119_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12951-020-00738-8","volume":"19","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Sun X, Wu B, Shang Y, Huang X, Dong H, et al. Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma. J Nanobiotechnol. 2021;19:8.","journal-title":"J Nanobiotechnol"},{"key":"1119_CR14","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"C-MJ Hu","year":"2011","unstructured":"Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci. 2011;108:10980\u20135.","journal-title":"Proc Natl Acad Sci."},{"key":"1119_CR15","doi-asserted-by":"publisher","first-page":"1900172","DOI":"10.1002\/advs.201900172","volume":"6","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhang K, Qin X, Li T, Qiu J, Yin T, et al. Biomimetic nanotherapies: red blood cell based core-shell structured nanocomplexes for atherosclerosis management. Adv Sci. 2019;6:1900172.","journal-title":"Adv Sci"},{"key":"1119_CR16","doi-asserted-by":"publisher","first-page":"1606209","DOI":"10.1002\/adma.201606209","volume":"29","author":"D Dehaini","year":"2017","unstructured":"Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29:1606209.","journal-title":"Adv Mater"},{"key":"1119_CR17","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao C, Huang Q, Liu C, Kwong CHT, Yue L, Wan J-B, et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun. 2020;11:2622.","journal-title":"Nat Commun"},{"key":"1119_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2009-08-237222","volume":"115","author":"S Vemula","year":"2010","unstructured":"Vemula S, Shi J, Hanneman P, Wei L, Kapur R. ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Blood. 2010;115:13.","journal-title":"Blood"},{"key":"1119_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7150\/thno.47841","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang K, Li T, Maruf A, Qin X, Luo L, et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11:164\u201380.","journal-title":"Theranostics"},{"key":"1119_CR20","doi-asserted-by":"publisher","first-page":"rbab033","DOI":"10.1093\/rb\/rbab033","volume":"8","author":"D Tang","year":"2021","unstructured":"Tang D, Wang Y, Wijaya A, Liu B, Maruf A, Wang J, et al. ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis. Regen Biomater. 2021;8:rbab033.","journal-title":"Regen Biomater."},{"key":"1119_CR21","doi-asserted-by":"publisher","first-page":"1801153","DOI":"10.1080\/20013078.2020.1801153","volume":"9","author":"B Hosseinkhani","year":"2020","unstructured":"Hosseinkhani B, Akker NMS, Molin DGM, Michiels L. (Sub)populations of extracellular vesicles released by TNF-\u03b1-triggered human endothelial cells promote vascular inflammation and monocyte migration. J Extracell Vesicles. 2020;9:1801153.","journal-title":"J Extracell Vesicles"},{"key":"1119_CR22","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1182\/blood-2014-11-611046","volume":"125","author":"M-S Njock","year":"2015","unstructured":"Njock M-S, Cheng HS, Dang LT, Nazari-Jahantigh M, Lau AC, Boudreau E, et al. Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. Blood. 2015;125:3202\u201312.","journal-title":"Blood"},{"key":"1119_CR23","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/s41467-017-02055-5","volume":"8","author":"I Goldstein","year":"2017","unstructured":"Goldstein I, Paakinaho V, Baek S, Sung M-H, Hager GL. Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading. Nat Commun. 2017;8:1849.","journal-title":"Nat Commun"},{"key":"1119_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2009-03-213967","volume":"115","author":"J Chen","year":"2010","unstructured":"Chen J, Fu X, Wang Y, Ling M, McMullen B, Kulman J, et al. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. Blood. 2010;115:706\u201312.","journal-title":"Blood"},{"key":"1119_CR25","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1038\/ncomms9995","volume":"6","author":"RJ Roth Flach","year":"2015","unstructured":"Roth Flach RJ, Skoura A, Matevossian A, Danai LV, Zheng W, Cortes C, et al. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis. Nat Commun. 2015;6:8995.","journal-title":"Nat Commun"},{"key":"1119_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature Mater. 2013;12:991\u20131003.","journal-title":"Nature Mater"},{"key":"1119_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12951-020-00629-y","volume":"18","author":"J Jin","year":"2020","unstructured":"Jin J, Zhao Q. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges. J Nanobiotechnol. 2020;18:75.","journal-title":"J Nanobiotechnol"},{"key":"1119_CR28","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1182\/blood-2015-01-544676","volume":"125","author":"SX Gu","year":"2015","unstructured":"Gu SX, Stevens JW, Lentz SR. Regulation of thrombosis and vascular function by protein methionine oxidation. Blood. 2015;125:3851\u20139.","journal-title":"Blood"},{"key":"1119_CR29","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1038\/s41467-019-13114-4","volume":"10","author":"Z Su","year":"2019","unstructured":"Su Z, Burchfield JG, Yang P, Humphrey SJ, Yang G, Francis D, et al. Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Nat Commun. 2019;10:5486.","journal-title":"Nat Commun"},{"key":"1119_CR30","doi-asserted-by":"publisher","first-page":"8943","DOI":"10.1021\/acsnano.8b02037","volume":"12","author":"Y Wang","year":"2018","unstructured":"Wang Y, Li L, Zhao W, Dou Y, An H, Tao H, et al. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano. 2018;12:8943\u201360.","journal-title":"ACS Nano"},{"key":"1119_CR31","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","volume":"12","author":"W Lv","year":"2018","unstructured":"Lv W, Xu J, Wang X, Li X, Xu Q, Xin H. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano. 2018;12:5417\u201326.","journal-title":"ACS Nano"},{"key":"1119_CR32","doi-asserted-by":"publisher","first-page":"1700147","DOI":"10.1002\/smtd.201700147","volume":"1","author":"J Zhuang","year":"2017","unstructured":"Zhuang J, Fang RH, Zhang L. Preparation of particulate polymeric therapeutics for medical applications. Small Meth. 2017;1:1700147.","journal-title":"Small Meth"},{"key":"1119_CR33","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1039\/C3NR06371B","volume":"6","author":"BT Luk","year":"2014","unstructured":"Luk BT, Hu C-MJ, Fang RH, Dehaini D, Carpenter C, Gao W, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014;6:2730.","journal-title":"Nanoscale."},{"key":"1119_CR34","doi-asserted-by":"publisher","first-page":"2004942","DOI":"10.1002\/adfm.202004942","volume":"30","author":"Y Li","year":"2020","unstructured":"Li Y, Liu Y, Ren Y, Su L, Li A, An Y, et al. Coating of a novel antimicrobial nanoparticle with a macrophage membrane for the selective entry into infected macrophages and killing of intracellular staphylococci. Adv Funct Mater. 2020;30:2004942.","journal-title":"Adv Funct Mater"},{"key":"1119_CR35","doi-asserted-by":"publisher","first-page":"119986","DOI":"10.1016\/j.biomaterials.2020.119986","volume":"245","author":"C Zhang","year":"2020","unstructured":"Zhang C, Peng S-Y, Hong S, Chen Q-W, Zeng X, Rong L, et al. Biomimetic carbon monoxide nanogenerator ameliorates streptozotocin induced type 1 diabetes in mice. Biomaterials. 2020;245:119986.","journal-title":"Biomaterials."},{"key":"1119_CR36","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/01.RES.0000149518.86865.3e","volume":"95","author":"A Schober","year":"2004","unstructured":"Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, et al. Crucial role of the CCL2\/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res. 2004;95:1125\u201333.","journal-title":"Circ Res"},{"key":"1119_CR37","doi-asserted-by":"publisher","first-page":"2002054","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32:2002054.","journal-title":"Adv Mater"},{"key":"1119_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Jamieson CHM, Pang WW, Park CY, Chao MP, Majeti R, et al. CD47 Is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138:271\u201385.","journal-title":"Cell"},{"key":"1119_CR39","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1084\/jem.20101974","volume":"209","author":"MH Han","year":"2012","unstructured":"Han MH, Lundgren DH, Jaiswal S, Chao M, Graham KL, Garris CS, et al. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J Exp Med. 2012;209:1325\u201334.","journal-title":"J Exp Med"},{"key":"1119_CR40","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","volume":"123","author":"R Jacamo","year":"2014","unstructured":"Jacamo R, Chen Y, Wang Z, Ma W, Zhang M, Spaeth EL, et al. Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance. Blood. 2014;123:2691\u2013702.","journal-title":"Blood"},{"key":"1119_CR41","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1038\/ncomms6160","volume":"5","author":"S-M Zhang","year":"2014","unstructured":"Zhang S-M, Zhu L-H, Chen H-Z, Zhang R, Zhang P, Jiang D-S, et al. Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat Commun. 2014;5:5160.","journal-title":"Nat Commun"},{"key":"1119_CR42","doi-asserted-by":"publisher","first-page":"2000021","DOI":"10.1002\/ppsc.202000021","volume":"37","author":"A Maruf","year":"2020","unstructured":"Maruf A, Wang Y, Luo L, Zhong Y, Nurhidayah D, Liu B, et al. Nanoerythrocyte membrane-enveloped ROS-responsive 5-aminolevulinic acid prodrug nanostructures with robust atheroprotection. Part Part Syst Char. 2020;37:2000021.","journal-title":"Part Part Syst Char"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-01119-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-021-01119-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-01119-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:09:09Z","timestamp":1675901349000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-021-01119-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1186\/s12951-021-01119-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed. All the animal care and experimental protocols were carried out with review and approval from the Laboratory Animal Welfare and Ethics Committee of Chongqing University (IACUC Issue No.: CQU-IACUC-RE-202109-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}